GoodRx

Forecast & Rating14 analysts currently cover GoodRx, with about 28.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $3.95, about 11.0% upside from the current price of $3.56. Price targets range from $2.65 to $5.00 — a wide spread, showing clear disagreement over just how much GoodRx can rise. Historically, about 52.5% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on GoodRx's outlook. Data as of Nov 7, 2026; for reference only and not investment advice.